The Latest
-
How CSL could save Australia from COVID-19
-
Moderna loses challenge to Arbutus patent on vaccine technology
-
Intel chip delay forces shift to using more outside factories, shares drop
-
Fed up of dividend cancellations? Buy these safe ASX dividend shares